BioSpace News Archive

Longeveron Inc., a clinical stage biotechnology company developing cellular therapies for chronic aging-related and life-threatening conditions, reported its financial results for the quarter and full year ended December 31, 2020 and provided a business update.

New Test on the BD Veritor™ Plus System Can Detect SARS-CoV-2, Influenza A, Influenza B from Single Patient Sample

Additional Capital from Flagship Pioneering, Joined by Invus, Fidelity Management & Research Company, Funds and Accounts Managed by BlackRock, Cowen, and Others

Fennec is Working Closely with its Third-Party Drug Product Manufacturer to Finalize the New Drug Application (NDA) Resubmission for PEDMARK™

RaySearch Laboratories AB announces an order from the Inova Department of Advanced Radiation Oncology and Proton Therapy in Alexandria and Fairfax regions of Virginia, significantly increasing the number of licenses to expand the use of RayStation® in both photon and proton treatment planning.

Clinical and pathological findings from clinical trial of the Bria-IMT™ regimen alone and in combination with immune checkpoint inhibitors in advanced breast cancer will be presented at the American Association for Cancer Research (AACR) Annual Meeting 2021, April 10-15 and May 17-21.

Nexelis and JOINN Laboratories announced that the two companies have signed a Letter of Intent to partner on supporting sponsors conducting bioanalytical studies in China.

Gestalt Diagnostics today announced, that BioReference Laboratories Inc., an OPKO Health company, has selected their digital pathology solution, PathFlow®, to support its pathology business.

The Ivy Brain Tumor Center at Barrow Neurological Institute, the largest early-phase drug development program for brain cancer in the world, has announced the dosing of its first patient in a first-in-human Phase 0 clinical trial of sonodynamic therapy (SDT), a noninvasive drug-device combination developed by SonALAsense in collaboration with Insightec.

Acutus Medical, Inc. (“Acutus”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, announced today that its management team will present at the 20th Annual Needham Virtual Healthcare Conference on Tuesday, April 13, 2021 at 3:45 p.m. Eastern Time.